SERTAD1 and carcinoma: Interestingly, gene-rank analysis using Oncomine Cancer Genome Portal and TIMER online analysis showed that TRIP-Br-1 has secured the top rank and differentially overexpressed in multiple carcinomas, including human BRCA (Finak’s datasets, fold change = 3.77, p = 1.52E–27)32 samples, rather than respective normal tissues.